Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Kidney Cancer Drug market report explains the definition, types, applications, major countries, and major players of the Kidney Cancer Drug market. The report mainly contains different types, applications, and regional historical data from 2017-2021 and forecast data from 2022-2028.
The report contains qualitative and quantitative analysis of the entire industry.
The influence of COVID-19 has been considered in the report. Coronavirus Impact is included in Chapter 2. In addition, Strategic Analytics to Boost Productivity and Profitability is included in Chapter 3.
By Player:
Prometheus Laboratories
Genentech
Cipla Limited
Immatics Biotechnologies
Amgen
Pfizer
Novartis AG
Exelixis
Bayer AG
Active Biotech
Glaxosmithkline PLC
Abbott Laboratories
F Hoffmann-La Roche
Onyx Pharmaceuticals
Aveo Pharmaceuticals
By Type:
Nexavar (Sorafenib)
Sutent (Sunitinib)
Afinitor (Everolimus)
Votrient (Pazopanib)
Avastin (Bevacizumab)
Inlyta (Axitinib),
Torisel (Temsirolimus)
Proleukin (Aldesleukin)
Other
By End-User:
Hospitals
Clinics
Research Center
Other
By Region:
North America
-
United States
-
Canada
-
Mexico
Europe
-
Germany
-
UK
-
Spain
-
France
-
Italy
-
Denmark
-
Finland
-
Norway
-
Sweden
-
Poland
-
Russia
-
Turkey
Asia-Pacific
-
China
-
Japan
-
India
-
South Korea
-
Pakistan
-
Bangladesh
-
Indonesia
-
Thailand
-
Singapore
-
Malaysia
-
Philippines
-
Vietnam
-
Others
South America
-
Brazil
-
Colombia
-
Chile
-
Argentina
-
Venezuela
-
Peru
-
Puerto Rico
-
Ecuador
-
Others
GCC
-
Bahrain
-
Kuwait
-
Oman
-
Qatar
-
Saudi Arabia
-
United Arab Emirates
Africa
-
Nigeria
-
South Africa
-
Egypt
-
Algeriat
-
Others
Oceania
-
Australia
-
New Zealand
TABLE OF CONTENT
1. Global Kidney Cancer Drug Executive Summary
-
1.1 Introduction
-
1.2 Market Panorama, 2022
2 Coronavirus Impact
-
2.1 Kidney Cancer Drug Outlook to 2028- Original Forecasts
-
2.2 Kidney Cancer Drug Outlook to 2028- COVID-19 Affected Forecasts
-
2.3 Impact on Industry
3 Strategic Analytics to Boost Productivity and Profitability
-
3.1 Potential Market Drivers and Opportunities
-
3.2 New Challenges and Strategies
-
3.3 Short Term and Long Term Kidney Cancer Drug Market Trends
4 Key Inferences
5 Market Overview
-
5.1 Current Market Scenario
-
5.2 Porter's Five Forces Analysis
-
5.2.1 Bargaining Power of Suppliers
-
5.2.2 Bargaining Power of Consumers
-
5.2.3 Threat of New Entrants
-
5.2.4 Threat of Substitute Product and Services
-
5.2.5 Competitive Rivalry within the Industry
6 Global Kidney Cancer Drug Market- Recent Developments
-
6.1 Kidney Cancer Drug Market News and Developments
-
6.2 Kidney Cancer Drug Market Deals Landscape
7 Kidney Cancer Drug Raw Materials and Cost Structure Analysis
-
7.1 Kidney Cancer Drug Key Raw Materials
-
7.2 Kidney Cancer Drug Price Trend of Key Raw Materials
-
7.3 Kidney Cancer Drug Key Suppliers of Raw Materials
-
7.4 Kidney Cancer Drug Market Concentration Rate of Raw Materials
-
7.5 Kidney Cancer Drug Cost Structure Analysis
-
7.5.1 Kidney Cancer Drug Raw Materials Analysis
-
7.5.2 Kidney Cancer Drug Labor Cost Analysis
-
7.5.3 Kidney Cancer Drug Manufacturing Expenses Analysis
8 Global Kidney Cancer Drug Import and Export Analysis (Top 10 Countries)
-
8.1 Global Kidney Cancer Drug Import by Region (Top 10 Countries) (2017-2028)
-
8.2 Global Kidney Cancer Drug Export by Region (Top 10 Countries) (2017-2028)
9 Global Kidney Cancer Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Kidney Cancer Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Nexavar (Sorafenib) Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Sutent (Sunitinib) Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Afinitor (Everolimus) Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Votrient (Pazopanib) Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Avastin (Bevacizumab) Consumption and Growth Rate (2017-2022)
-
9.1.6 Global Inlyta (Axitinib), Consumption and Growth Rate (2017-2022)
-
9.1.7 Global Torisel (Temsirolimus) Consumption and Growth Rate (2017-2022)
-
9.1.8 Global Proleukin (Aldesleukin) Consumption and Growth Rate (2017-2022)
-
9.1.9 Global Other Consumption and Growth Rate (2017-2022)
-
9.2 Global Kidney Cancer Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Research Center Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Region and Country-wise Kidney Cancer Drug Market Analysis and Outlook till 2022
-
10.1 Global Kidney Cancer Drug Consumption (2017-2022)
-
10.2 North America Consumption Analysis
-
10.2.1 United States Kidney Cancer Drug Consumption (2017-2022)
-
10.2.2 Canada Kidney Cancer Drug Consumption (2017-2022)
-
10.2.3 Mexico Kidney Cancer Drug Consumption (2017-2022)
-
10.3 Europe Consumption Analysis
-
10.3.1 Germany Kidney Cancer Drug Consumption (2017-2022)
-
10.3.2 UK Kidney Cancer Drug Consumption (2017-2022)
-
10.3.3 Spain Kidney Cancer Drug Consumption (2017-2022)
-
10.3.4 Belgium Kidney Cancer Drug Consumption (2017-2022)
-
10.3.5 France Kidney Cancer Drug Consumption (2017-2022)
-
10.3.6 Italy Kidney Cancer Drug Consumption (2017-2022)
-
10.3.7 Denmark Kidney Cancer Drug Consumption (2017-2022)
-
10.3.8 Finland Kidney Cancer Drug Consumption (2017-2022)
-
10.3.9 Norway Kidney Cancer Drug Consumption (2017-2022)
-
10.3.10 Sweden Kidney Cancer Drug Consumption (2017-2022)
-
10.3.11 Poland Kidney Cancer Drug Consumption (2017-2022)
-
10.3.12 Russia Kidney Cancer Drug Consumption (2017-2022)
-
10.3.13 Turkey Kidney Cancer Drug Consumption (2017-2022)
-
10.4 APAC Consumption Analysis
-
10.4.1 China Kidney Cancer Drug Consumption (2017-2022)
-
10.4.2 Japan Kidney Cancer Drug Consumption (2017-2022)
-
10.4.3 India Kidney Cancer Drug Consumption (2017-2022)
-
10.4.4 South Korea Kidney Cancer Drug Consumption (2017-2022)
-
10.4.5 Pakistan Kidney Cancer Drug Consumption (2017-2022)
-
10.4.6 Bangladesh Kidney Cancer Drug Consumption (2017-2022)
-
10.4.7 Indonesia Kidney Cancer Drug Consumption (2017-2022)
-
10.4.8 Thailand Kidney Cancer Drug Consumption (2017-2022)
-
10.4.9 Singapore Kidney Cancer Drug Consumption (2017-2022)
-
10.4.10 Malaysia Kidney Cancer Drug Consumption (2017-2022)
-
10.4.11 Philippines Kidney Cancer Drug Consumption (2017-2022)
-
10.4.12 Vietnam Kidney Cancer Drug Consumption (2017-2022)
-
10.5 South America Consumption Analysis
-
10.5.1 Brazil Kidney Cancer Drug Consumption (2017-2022)
-
10.5.2 Colombia Kidney Cancer Drug Consumption (2017-2022)
-
10.5.3 Chile Kidney Cancer Drug Consumption (2017-2022)
-
10.5.4 Argentina Kidney Cancer Drug Consumption (2017-2022)
-
10.5.5 Venezuela Kidney Cancer Drug Consumption (2017-2022)
-
10.5.6 Peru Kidney Cancer Drug Consumption (2017-2022)
-
10.5.7 Puerto Rico Kidney Cancer Drug Consumption (2017-2022)
-
10.5.8 Ecuador Kidney Cancer Drug Consumption (2017-2022)
-
10.6 GCC Consumption Analysis
-
10.6.1 Bahrain Kidney Cancer Drug Consumption (2017-2022)
-
10.6.2 Kuwait Kidney Cancer Drug Consumption (2017-2022)
-
10.6.3 Oman Kidney Cancer Drug Consumption (2017-2022)
-
10.6.4 Qatar Kidney Cancer Drug Consumption (2017-2022)
-
10.6.5 Saudi Arabia Kidney Cancer Drug Consumption (2017-2022)
-
10.6.6 United Arab Emirates Kidney Cancer Drug Consumption (2017-2022)
-
10.7 Africa Consumption Analysis
-
10.7.1 Nigeria Kidney Cancer Drug Consumption (2017-2022)
-
10.7.2 South Africa Kidney Cancer Drug Consumption (2017-2022)
-
10.7.3 Egypt Kidney Cancer Drug Consumption (2017-2022)
-
10.7.4 Algeria Kidney Cancer Drug Consumption (2017-2022)
-
10.8 Oceania Consumption Analysis
-
10.8.1 Australia Kidney Cancer Drug Consumption (2017-2022)
-
10.8.2 New Zealand Kidney Cancer Drug Consumption (2017-2022)
11 Global Kidney Cancer Drug Competitive Analysis
-
11.1 Prometheus Laboratories
-
11.1.1 Prometheus Laboratories Company Details
-
11.1.2 Prometheus Laboratories Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.1.3 Prometheus Laboratories Kidney Cancer Drug Main Business and Markets Served
-
11.1.4 Prometheus Laboratories Kidney Cancer Drug Product Portfolio
-
11.1.5 Recent Research and Development Strategies
-
11.2 Genentech
-
11.2.1 Genentech Company Details
-
11.2.2 Genentech Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.2.3 Genentech Kidney Cancer Drug Main Business and Markets Served
-
11.2.4 Genentech Kidney Cancer Drug Product Portfolio
-
11.2.5 Recent Research and Development Strategies
-
11.3 Cipla Limited
-
11.3.1 Cipla Limited Company Details
-
11.3.2 Cipla Limited Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.3.3 Cipla Limited Kidney Cancer Drug Main Business and Markets Served
-
11.3.4 Cipla Limited Kidney Cancer Drug Product Portfolio
-
11.3.5 Recent Research and Development Strategies
-
11.4 Immatics Biotechnologies
-
11.4.1 Immatics Biotechnologies Company Details
-
11.4.2 Immatics Biotechnologies Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.4.3 Immatics Biotechnologies Kidney Cancer Drug Main Business and Markets Served
-
11.4.4 Immatics Biotechnologies Kidney Cancer Drug Product Portfolio
-
11.4.5 Recent Research and Development Strategies
-
11.5 Amgen
-
11.5.1 Amgen Company Details
-
11.5.2 Amgen Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.5.3 Amgen Kidney Cancer Drug Main Business and Markets Served
-
11.5.4 Amgen Kidney Cancer Drug Product Portfolio
-
11.5.5 Recent Research and Development Strategies
-
11.6 Pfizer
-
11.6.1 Pfizer Company Details
-
11.6.2 Pfizer Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.6.3 Pfizer Kidney Cancer Drug Main Business and Markets Served
-
11.6.4 Pfizer Kidney Cancer Drug Product Portfolio
-
11.6.5 Recent Research and Development Strategies
-
11.7 Novartis AG
-
11.7.1 Novartis AG Company Details
-
11.7.2 Novartis AG Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.7.3 Novartis AG Kidney Cancer Drug Main Business and Markets Served
-
11.7.4 Novartis AG Kidney Cancer Drug Product Portfolio
-
11.7.5 Recent Research and Development Strategies
-
11.8 Exelixis
-
11.8.1 Exelixis Company Details
-
11.8.2 Exelixis Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.8.3 Exelixis Kidney Cancer Drug Main Business and Markets Served
-
11.8.4 Exelixis Kidney Cancer Drug Product Portfolio
-
11.8.5 Recent Research and Development Strategies
-
11.9 Bayer AG
-
11.9.1 Bayer AG Company Details
-
11.9.2 Bayer AG Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.9.3 Bayer AG Kidney Cancer Drug Main Business and Markets Served
-
11.9.4 Bayer AG Kidney Cancer Drug Product Portfolio
-
11.9.5 Recent Research and Development Strategies
-
11.10 Active Biotech
-
11.10.1 Active Biotech Company Details
-
11.10.2 Active Biotech Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.10.3 Active Biotech Kidney Cancer Drug Main Business and Markets Served
-
11.10.4 Active Biotech Kidney Cancer Drug Product Portfolio
-
11.10.5 Recent Research and Development Strategies
-
11.11 Glaxosmithkline PLC
-
11.11.1 Glaxosmithkline PLC Company Details
-
11.11.2 Glaxosmithkline PLC Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.11.3 Glaxosmithkline PLC Kidney Cancer Drug Main Business and Markets Served
-
11.11.4 Glaxosmithkline PLC Kidney Cancer Drug Product Portfolio
-
11.11.5 Recent Research and Development Strategies
-
11.12 Abbott Laboratories
-
11.12.1 Abbott Laboratories Company Details
-
11.12.2 Abbott Laboratories Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.12.3 Abbott Laboratories Kidney Cancer Drug Main Business and Markets Served
-
11.12.4 Abbott Laboratories Kidney Cancer Drug Product Portfolio
-
11.12.5 Recent Research and Development Strategies
-
11.13 F Hoffmann-La Roche
-
11.13.1 F Hoffmann-La Roche Company Details
-
11.13.2 F Hoffmann-La Roche Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.13.3 F Hoffmann-La Roche Kidney Cancer Drug Main Business and Markets Served
-
11.13.4 F Hoffmann-La Roche Kidney Cancer Drug Product Portfolio
-
11.13.5 Recent Research and Development Strategies
-
11.14 Onyx Pharmaceuticals
-
11.14.1 Onyx Pharmaceuticals Company Details
-
11.14.2 Onyx Pharmaceuticals Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.14.3 Onyx Pharmaceuticals Kidney Cancer Drug Main Business and Markets Served
-
11.14.4 Onyx Pharmaceuticals Kidney Cancer Drug Product Portfolio
-
11.14.5 Recent Research and Development Strategies
-
11.15 Aveo Pharmaceuticals
-
11.15.1 Aveo Pharmaceuticals Company Details
-
11.15.2 Aveo Pharmaceuticals Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
11.15.3 Aveo Pharmaceuticals Kidney Cancer Drug Main Business and Markets Served
-
11.15.4 Aveo Pharmaceuticals Kidney Cancer Drug Product Portfolio
-
11.15.5 Recent Research and Development Strategies
12 Global Kidney Cancer Drug Market Outlook by Types and Applications to 2028
-
12.1 Global Kidney Cancer Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
12.1.1 Global Nexavar (Sorafenib) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.2 Global Sutent (Sunitinib) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.3 Global Afinitor (Everolimus) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.4 Global Votrient (Pazopanib) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.5 Global Avastin (Bevacizumab) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.6 Global Inlyta (Axitinib), Consumption Forecast and Growth Rate (2022-2028)
-
12.1.7 Global Torisel (Temsirolimus) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.8 Global Proleukin (Aldesleukin) Consumption Forecast and Growth Rate (2022-2028)
-
12.1.9 Global Other Consumption Forecast and Growth Rate (2022-2028)
-
12.2 Global Kidney Cancer Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
12.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
12.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
12.2.3 Global Research Center Consumption Forecast and Growth Rate (2022-2028)
-
12.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
13 Country-wise Kidney Cancer Drug Market Analysis and Outlook to 2028
-
13.1 Global Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.2 North America Consumption Analysis
-
13.2.1 United States Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.2.2 Canada Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.2.3 Mexico Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.3 Europe Consumption Analysis
-
13.3.1 Germany Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.3.2 UK Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.3.3 Spain Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.3.4 Belgium Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.3.5 France Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.3.6 Italy Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.3.7 Denmark Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.3.8 Finland Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.3.9 Norway Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.3.10 Sweden Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.3.11 Poland Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.3.12 Russia Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.3.13 Turkey Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.4 APAC Consumption Analysis
-
13.4.1 China Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.4.2 Japan Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.4.3 India Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.4.4 South Korea Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.4.5 Pakistan Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.4.6 Bangladesh Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.4.7 Indonesia Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.4.8 Thailand Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.4.9 Singapore Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.4.10 Malaysia Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.4.11 Philippines Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.4.12 Vietnam Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.5 South America Consumption Analysis
-
13.5.1 Brazil Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.5.2 Colombia Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.5.3 Chile Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.5.4 Argentina Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.5.5 Venezuela Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.5.6 Peru Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.5.7 Puerto Rico Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.5.8 Ecuador Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.6 GCC Consumption Analysis
-
13.6.1 Bahrain Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.6.2 Kuwait Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.6.3 Oman Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.6.4 Qatar Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.6.5 Saudi Arabia Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.6.6 United Arab Emirates Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.7 Africa Consumption Analysis
-
13.7.1 Nigeria Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.7.2 South Africa Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.7.3 Egypt Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.7.4 Algeria Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.8 Oceania Consumption Analysis
-
13.8.1 Australia Kidney Cancer Drug Consumption Forecast (2022-2028)
-
13.8.2 New Zealand Kidney Cancer Drug Consumption Forecast (2022-2028)
14 Conclusions
The List of Tables and Figures
-
Table Definition of Kidney Cancer Drug
-
Figure of Kidney Cancer Drug Picture
-
Table Global Kidney Cancer Drug Import by Region (Top 10 Countries) (2017-2028)
-
Table Global Kidney Cancer Drug Export by Region (Top 10 Countries) (2017-2028)
-
Figure Global Nexavar (Sorafenib) Consumption and Growth Rate (2017-2022)
-
Figure Global Sutent (Sunitinib) Consumption and Growth Rate (2017-2022)
-
Figure Global Afinitor (Everolimus) Consumption and Growth Rate (2017-2022)
-
Figure Global Votrient (Pazopanib) Consumption and Growth Rate (2017-2022)
-
Figure Global Avastin (Bevacizumab) Consumption and Growth Rate (2017-2022)
-
Figure Global Inlyta (Axitinib), Consumption and Growth Rate (2017-2022)
-
Figure Global Torisel (Temsirolimus) Consumption and Growth Rate (2017-2022)
-
Figure Global Proleukin (Aldesleukin) Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Research Center Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global Kidney Cancer Drug Consumption by Country (2017-2022)
-
Table North America Kidney Cancer Drug Consumption by Country (2017-2022)
-
Figure United States Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Canada Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Mexico Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Kidney Cancer Drug Consumption by Country (2017-2022)
-
Figure Germany Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure UK Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Spain Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Belgium Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure France Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Italy Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Denmark Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Finland Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Norway Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Sweden Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Poland Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Russia Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Turkey Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Table APAC Kidney Cancer Drug Consumption by Country (2017-2022)
-
Figure China Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure India Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Pakistan Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Bangladesh Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Indonesia Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Thailand Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Singapore Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Malaysia Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Philippines Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Vietnam Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Table South America Kidney Cancer Drug Consumption by Country (2017-2022)
-
Figure Brazil Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Colombia Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Chile Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Argentina Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Venezuela Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Peru Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Puerto Rico Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Ecuador Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Table GCC Kidney Cancer Drug Consumption by Country (2017-2022)
-
Figure Bahrain Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Kuwait Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Oman Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Qatar Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Saudi Arabia Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure United Arab Emirates Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Table Africa Kidney Cancer Drug Consumption by Country (2017-2022)
-
Figure Nigeria Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure South Africa Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Egypt Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure Algeria Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Table Oceania Kidney Cancer Drug Consumption by Country (2017-2022)
-
Figure Australia Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Figure New Zealand Kidney Cancer Drug Consumption and Growth Rate (2017-2022)
-
Table Prometheus Laboratories Company Details
-
Table Prometheus Laboratories Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Prometheus Laboratories Kidney Cancer Drug Main Business and Markets Served
-
Table Prometheus Laboratories Kidney Cancer Drug Product Portfolio
-
Table Genentech Company Details
-
Table Genentech Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Genentech Kidney Cancer Drug Main Business and Markets Served
-
Table Genentech Kidney Cancer Drug Product Portfolio
-
Table Cipla Limited Company Details
-
Table Cipla Limited Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Limited Kidney Cancer Drug Main Business and Markets Served
-
Table Cipla Limited Kidney Cancer Drug Product Portfolio
-
Table Immatics Biotechnologies Company Details
-
Table Immatics Biotechnologies Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Immatics Biotechnologies Kidney Cancer Drug Main Business and Markets Served
-
Table Immatics Biotechnologies Kidney Cancer Drug Product Portfolio
-
Table Amgen Company Details
-
Table Amgen Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amgen Kidney Cancer Drug Main Business and Markets Served
-
Table Amgen Kidney Cancer Drug Product Portfolio
-
Table Pfizer Company Details
-
Table Pfizer Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Kidney Cancer Drug Main Business and Markets Served
-
Table Pfizer Kidney Cancer Drug Product Portfolio
-
Table Novartis AG Company Details
-
Table Novartis AG Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Kidney Cancer Drug Main Business and Markets Served
-
Table Novartis AG Kidney Cancer Drug Product Portfolio
-
Table Exelixis Company Details
-
Table Exelixis Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Exelixis Kidney Cancer Drug Main Business and Markets Served
-
Table Exelixis Kidney Cancer Drug Product Portfolio
-
Table Bayer AG Company Details
-
Table Bayer AG Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bayer AG Kidney Cancer Drug Main Business and Markets Served
-
Table Bayer AG Kidney Cancer Drug Product Portfolio
-
Table Active Biotech Company Details
-
Table Active Biotech Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Active Biotech Kidney Cancer Drug Main Business and Markets Served
-
Table Active Biotech Kidney Cancer Drug Product Portfolio
-
Table Glaxosmithkline PLC Company Details
-
Table Glaxosmithkline PLC Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Glaxosmithkline PLC Kidney Cancer Drug Main Business and Markets Served
-
Table Glaxosmithkline PLC Kidney Cancer Drug Product Portfolio
-
Table Abbott Laboratories Company Details
-
Table Abbott Laboratories Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Abbott Laboratories Kidney Cancer Drug Main Business and Markets Served
-
Table Abbott Laboratories Kidney Cancer Drug Product Portfolio
-
Table F Hoffmann-La Roche Company Details
-
Table F Hoffmann-La Roche Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table F Hoffmann-La Roche Kidney Cancer Drug Main Business and Markets Served
-
Table F Hoffmann-La Roche Kidney Cancer Drug Product Portfolio
-
Table Onyx Pharmaceuticals Company Details
-
Table Onyx Pharmaceuticals Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Onyx Pharmaceuticals Kidney Cancer Drug Main Business and Markets Served
-
Table Onyx Pharmaceuticals Kidney Cancer Drug Product Portfolio
-
Table Aveo Pharmaceuticals Company Details
-
Table Aveo Pharmaceuticals Kidney Cancer Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Aveo Pharmaceuticals Kidney Cancer Drug Main Business and Markets Served
-
Table Aveo Pharmaceuticals Kidney Cancer Drug Product Portfolio
-
Figure Global Nexavar (Sorafenib) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Sutent (Sunitinib) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Afinitor (Everolimus) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Votrient (Pazopanib) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Avastin (Bevacizumab) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Inlyta (Axitinib), Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Torisel (Temsirolimus) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Proleukin (Aldesleukin) Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Research Center Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Kidney Cancer Drug Consumption Forecast by Country (2022-2028)
-
Table North America Kidney Cancer Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Canada Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Mexico Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Kidney Cancer Drug Consumption Forecast by Country (2022-2028)
-
Figure Germany Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure UK Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Spain Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Belgium Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure France Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Italy Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Denmark Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Finland Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Norway Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Sweden Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Poland Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Russia Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Turkey Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table APAC Kidney Cancer Drug Consumption Forecast by Country (2022-2028)
-
Figure China Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Pakistan Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Bangladesh Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Indonesia Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Thailand Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Singapore Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Malaysia Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Philippines Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Vietnam Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table South America Kidney Cancer Drug Consumption Forecast by Country (2022-2028)
-
Figure Brazil Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Colombia Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Chile Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Argentina Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Venezuela Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Peru Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Puerto Rico Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Ecuador Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table GCC Kidney Cancer Drug Consumption Forecast by Country (2022-2028)
-
Figure Bahrain Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Kuwait Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Oman Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Qatar Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Saudi Arabia Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure United Arab Emirates Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Africa Kidney Cancer Drug Consumption Forecast by Country (2022-2028)
-
Figure Nigeria Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Africa Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Egypt Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Algeria Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Oceania Kidney Cancer Drug Consumption Forecast by Country (2022-2028)
-
Figure Australia Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure New Zealand Kidney Cancer Drug Consumption Forecast and Growth Rate (2022-2028)
-
